Get 20% lifetime commission for referring investors to digrin.com
here.
Suven Pharmaceuticals Ltd - Price History
Monthly price history for SUVENPHAR.NS (Suven Pharmaceuticals Ltd)
Date | Adjusted price | Real price |
---|---|---|
May 2024 | ₹644.15 | ₹644.15 |
April 2024 | ₹660.45 | ₹660.45 |
March 2024 | ₹677.10 | ₹677.10 |
February 2024 | ₹629.40 | ₹629.40 |
January 2024 | ₹672.80 | ₹672.80 |
December 2023 | ₹722.80 | ₹722.80 |
November 2023 | ₹659.70 | ₹659.70 |
October 2023 | ₹578.70 | ₹578.70 |
September 2023 | ₹561.35 | ₹561.35 |
August 2023 | ₹512.65 | ₹512.65 |
July 2023 | ₹494.80 | ₹494.80 |
June 2023 | ₹485.85 | ₹485.85 |
May 2023 | ₹477 | ₹477 |
April 2023 | ₹471.90 | ₹471.90 |
March 2023 | ₹472.40 | ₹472.40 |
February 2023 | ₹479.95 | ₹479.95 |
January 2023 | ₹493.05 | ₹493.05 |
December 2022 | ₹494.90 | ₹494.90 |
November 2022 | ₹464.85 | ₹464.85 |
October 2022 | ₹398.35 | ₹398.35 |
September 2022 | ₹450.95 | ₹450.95 |
August 2022 | ₹486.10 | ₹491.10 |
July 2022 | ₹473.48 | ₹478.35 |
June 2022 | ₹457.60 | ₹462.30 |
May 2022 | ₹494.86 | ₹499.95 |
April 2022 | ₹596.25 | ₹603.55 |
March 2022 | ₹610.97 | ₹618.45 |
February 2022 | ₹506.25 | ₹512.45 |
January 2022 | ₹528.22 | ₹536.85 |
December 2021 | ₹485.32 | ₹493.25 |
November 2021 | ₹478.83 | ₹486.65 |
October 2021 | ₹500.43 | ₹508.60 |
September 2021 | ₹519.76 | ₹528.25 |
August 2021 | ₹527.44 | ₹536.05 |
July 2021 | ₹497.25 | ₹506.30 |
June 2021 | ₹471.37 | ₹479.95 |
May 2021 | ₹504.96 | ₹514.15 |
April 2021 | ₹531.38 | ₹541.05 |
March 2021 | ₹487.92 | ₹496.80 |
February 2021 | ₹470.83 | ₹479.40 |
January 2021 | ₹452.73 | ₹461.90 |
December 2020 | ₹443.33 | ₹452.30 |
November 2020 | ₹389.07 | ₹396.95 |
October 2020 | ₹307.87 | ₹314.10 |
September 2020 | ₹372.56 | ₹380.10 |
August 2020 | ₹310.91 | ₹317.20 |
July 2020 | ₹310.34 | ₹316.63 |
June 2020 | ₹230.53 | ₹235.20 |
May 2020 | ₹152.76 | ₹155.85 |
April 2020 | ₹145.36 | ₹148.30 |
March 2020 | ₹98.53 | ₹100.53 |
SUVENPHAR.NS
Price: ₹644.15
52 week price:
Earnings Per Share: 14.56 INR
P/E Ratio: 39.24
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 165.2 billion
Average Dividend Frequency: 3